International Clinical Trial: An Open-Label, Multi-Cohort, Multi-Center Phase Ib/II Study to Evaluate the Safety and Efficacy of GB268 Monotherapy or Combination Therapy in Patients With Locally Advanced or Metastatic Breast Cancer

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129246) titled 'An Open-Label, Multi-Cohort, Multi-Center Phase Ib/II Study to Evaluate the Safety and Efficacy of GB268 Monotherapy or Combination Therapy in Patients With Locally Advanced or Metastatic Breast Cancer' on Aug. 1.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

Condition: Locally advanced unresectable or metastatic cancer

Intervention: Cohort F: GB268 + Albumin Paclitaxel for Injection:GB268 + Albumin Paclitaxel for Injection Cohort E: GB268 + Dedatuximab for Injection:GB268 + Dedatuximab for Injection Cohort D: GB268 + Leralcil H...